Resumen
Meibomitis is an ocular disease which leads to a dysfunction of the meibomian glands. This ophthalmologic disease may cause severe pain and obvious vision loss. The therapeutic protocol used in the treatment of this pathology consists in local and systemic antibiotic therapy. The results obtained using this approach are scarce and, in many cases, result in adverse events. In this study, we propose an alternative and original approach using TECAR therapy in the treatments of meibomitis disease. The endogenous heat produced by the TECAR device produced beneficial effects from both a histological and anatomical point of view. Different parameters (TBUT, interferometry, tear meniscus height, meibography and OCTA) were evaluated before the TECAR treatments, immediately afterwards, and 15 days after the end of the treatments. The obtained results suggest a new possible use of TECAR therapy on ophthalmological patients, opening an innovative scenario in a non-invasive manner.